Evidence map›Paper›PMID 32000660›Full record

ArticleMolecular medicine (Cambridge, Mass.)2020

Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.

Zhihang Chen, Chun Wang, Hao Dong, Xing Wang, Feng Gao, Sen Zhang, Xiaolong Zhang

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Iron, inflammation, and intestinal tumors: the crucial triad in colorectal cancer progression and therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhihang ChenDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
Chun WangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430000, China.
Hao DongDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
Xing WangDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
Feng GaoDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
Sen ZhangDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
Xiaolong ZhangDepartment of Colorectal and Anal Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China. 1368913114@qq.com.ORCID 0000-0002-1145-9429
Guangxi Medical University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAspirin, as a non-steroidal anti-inflammatory drug, can improve the survival rate of patients with colorectal cancer, while aspirin is effective in patients with PIK3CA mutant colorectal cancer (CRC). However, the mechanism of aspirin in the treatment of PIK3CA mutated CRC patients remains unclear.

methodsIn this study, immunohistochemistry was used to detect the expression levels of PI3K and Raptor in colorectal cancer patients with PIK3CA mutation and PIK3CA wild-type patients. To demonstrate that aspirin has a better effect on the CRC of PIK3CA mutations in association with the PI3K/Akt/Raptor pathway, we used aspirin to treat PIK3CA mutant CRC cells (HCT-116 and RKO). Subsequently, the CCK8 assay and flow cytometry assay were used to detect the apoptosis of PIK3CA mutant CRC cells before and after aspirin use. Western blot was used to detect the changes of PI3K/Akt/Raptor-associated protein, autophagy protein microtubule associated protein 1 light chain 3 alpha (MAP1LC3A, LC3), beclin 1 (BECN1) and apoptosis protein BCL2-associated X protein/ BCL2 apoptosis regulator (Bax/Bcl2), Caspase 3 after treatment of CRC cells with PIK3CA mutation by aspirin.

resultsPhosphoinositide-3-kinase (PI3K) and regulatory associated protein of MTOR complex 1 (Raptor) protein expression levels were higher in PIK3CA-mutant patients than in IK3CA wild-type patients. The expression of Bax/Bcl2 increased after treatment indicates that aspirin can induce apoptosis of PIK3CA-mutant CRC cells. The expression level of MAP1LC3 (LC3) in cells increases with the concentration of aspirin demonstrates that aspirin can induce autophagy in CRC cells. After 48 h of treatment with aspirin, the phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) and ribosomal protein S6 kinase B1 (S6K1) was reduced, cell proliferation has been inhibited. After treatment with aspirin, as phosphorylation of PI3K and Protein kinase B (PKB, Akt) was decreased, Raptor expression was also decreased.

conclusionAspirin can regulate the proliferation, apoptosis and autophagy of CRC cells through the PI3K/Akt/Raptor pathway, affecting PIK3CA-mutant CRC.

Indexed as

AspirinAutophagyCell Line, TumorCell ProliferationCell SurvivalClass I Phosphatidylinositol 3-KinasesColorectal NeoplasmsFemaleGene Expression Regulation, NeoplasticHCT116 CellsHumansMaleMutationPhosphatidylinositol 3-KinasePhosphorylationProto-Oncogene Proteins c-aktAspirinClass I Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasePIK3CA protein, humanProto-Oncogene Proteins c-aktRegulatory-Associated Protein of mTORRPTOR protein, humanAspirinColorectal cancerPI3K/Akt/raptor pathwayPIK3CA mutated

Identifiers

PMID32000660
PMCPMC6993447
OpenAlexW3003762618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.